Clinical Trials Directory

Trials / Completed

CompletedNCT00766493

GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (EMBOLDEN)

GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (GORE EMBOLDEN)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
250 (actual)
Sponsor
W.L.Gore & Associates · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Compare the 30-day safety and efficacy of the GORE® Embolic Filter used in conjunction with FDA-approved carotid stents to a performance goal obtained from carotid stent studies utilizing distal embolic protection.

Detailed description

Continuous advances in angioplasty techniques and the development of low-profile, flexible, tapered nitinol stents designed specifically for carotid applications have made CAS a viable alternative to CEA. Advances in embolic protection technology will assist in moving CAS forward as a universally accepted procedure. While the GORE® Embolic Filter is similar in many ways to other currently available filters, it has been designed to provide optimal vessel wall apposition. Bench tests suggest that the wall apposition may provide improved filter efficiency, thereby minimizing embolization of particles downstream and potentially decreasing adverse clinical effects. In addition, preclinical testing suggests that the GORE® Embolic Filter has improved deliverability, including torque ability and lesion cross that may improve the ability of the system to access and treat tight lesions in tortuous anatomy. Thus, the purpose of this multi-center clinical study is to assess the safety and effectiveness of the GORE® Embolic Filter when used to provide cerebral embolic protection during carotid artery angioplasty and stenting.

Conditions

Interventions

TypeNameDescription
DEVICEGORE® Embolic FilterEmbolic protection during carotid stenting

Timeline

Start date
2009-01-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2008-10-06
Last updated
2016-09-29
Results posted
2012-08-07

Source: ClinicalTrials.gov record NCT00766493. Inclusion in this directory is not an endorsement.